WA
RXII

WealthTrust-Arizona’s GALENA BIOPHARMA INC COM RXII Stock Holding History

WealthTrust-Arizona’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-138
Closed – – 707
2014
Q3 		$0 Hold
138
– – ﹤0.01% 687
2014
Q2 		$0 Hold
138
– – ﹤0.01% 766
2014
Q1 		$0 Buy
+138
New – ﹤0.01% 753

Other funds holding RXII

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

WealthTrust-Arizona's RXII Position: Q4 2014 in Review

WealthTrust-Arizona sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2014, closing a stake of 138 shares.

WealthTrust-Arizona first reported a position in RXII in Q1 2014 and held it in 3 quarters. The position peaked at $0 in Q3 2014. 79 funds tracked by Wall St. Rank hold RXII as of Q4 2014.

  • WealthTrust-Arizona reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2014 after selling out during the quarter.
  • WealthTrust-Arizona sold 138 GALENA BIOPHARMA INC COM shares in Q4 2014.
  • WealthTrust-Arizona first reported a position in GALENA BIOPHARMA INC COM in Q1 2014 and held it in 3 quarters.
  • WealthTrust-Arizona's GALENA BIOPHARMA INC COM position peaked at $0 in Q3 2014.
  • 79 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2014.

Based on WealthTrust-Arizona's 13F filing for Q4 2014, filed 22 Jan 2015.